Human 20α–Hydroxysteroid Dehydrogenase: Crystallographic and Site-directed Mutagenesis Studies Lead to the Identification of an Alternative Binding Site for C21-steroids
暂无分享,去创建一个
Fernand Labrie | Pierre Legrand | Jean-François Couture | Pierre Legrand | R. Breton | F. Labrie | J. Couture | Van Luu-The | V. Luu‐The | Line Cantin | Rock Breton | L. Cantin
[1] K. Bohren,et al. The C-terminal loop of aldehyde reductase determines the substrate and inhibitor specificity. , 1996, Biochemistry.
[2] V. Luu‐The,et al. Characterization of a human 20alpha-hydroxysteroid dehydrogenase. , 2000, Journal of molecular endocrinology.
[3] J. Fontecilla-Camps,et al. Unusual Charge Stabilization of NADP+ in 17β-Hydroxysteroid Dehydrogenase* , 1998, The Journal of Biological Chemistry.
[4] P. K. Talwalker,et al. Maintenance of Pregnancy in Spayed Rats with 20α-Hydroxypregn-4-ene-3-one and 20β-Hydroxypregn-4-ene-3-one , 1966, Nature.
[5] Sheng-Xiang Lin,et al. Crystallization and preliminary X-ray crystallographic analysis of the human type 3 3α-hydroxysteroid dehydrogenase at 1.8 Å resolution , 2001 .
[6] T. Penning,et al. The arginine 276 anchor for NADP(H) dictates fluorescence kinetic transients in 3 alpha-hydroxysteroid dehydrogenase, a representative aldo-keto reductase. , 1999, Biochemistry.
[7] Lenton Ea,et al. The endocrinology of conception cycles and implantation in women. , 1988 .
[8] T. Penning,et al. The kinetic mechanism catalysed by homogeneous rat liver 3 alpha-hydroxysteroid dehydrogenase. Evidence for binary and ternary dead-end complexes containing non-steroidal anti-inflammatory drugs. , 1991, The Biochemical journal.
[9] Haiching Ma,et al. Conversion of mammalian 3alpha-hydroxysteroid dehydrogenase to 20alpha-hydroxysteroid dehydrogenase using loop chimeras: changing specificity from androgens to progestins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[10] N. Palackal,et al. Crystal structure of human type III 3alpha-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate. , 2001, Biochemistry.
[11] D. Willey,et al. Bacterial morphine dehydrogenase further defines a distinct superfamily of oxidoreductases with diverse functional activities. , 1994, The Biochemical journal.
[12] Pierre Legrand,et al. Structure of the Human 3α-Hydroxysteroid Dehydrogenase Type 3 in Complex with Testosterone and NADP at 1.25-Å Resolution* , 2001, The Journal of Biological Chemistry.
[13] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[14] K. Sato,et al. Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells. , 1996, The Biochemical journal.
[15] S. Paul,et al. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. , 1986, Science.
[16] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[17] D. Poirier,et al. Characteristics of human types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities: Oxidation/reduction and inhibition , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[18] M. Lewis,et al. Three-dimensional structure of rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] Michael E. Burczynski,et al. Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones , 2000 .
[20] T. Penning,et al. Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7, 8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a]pyrene-7,8-dione. , 1998, Biochemistry.
[21] Pierre Legrand,et al. Expression, crystallization and preliminary X-ray analysis of human and rabbit 20alpha-hydroxysteroid dehydrogenases in complex with NADP(H) and various steroid substrates. , 2002, Acta crystallographica. Section D, Biological crystallography.
[22] G. Petsko,et al. Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and crystal structure of the Y48H mutant enzyme. , 1994, Biochemistry.
[23] M. J. Bennett,et al. Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase. , 1997, Structure.
[24] Y. Sasaguri,et al. Close kinship of human 20α‐hydroxysteroid dehydrogenase gene with three aldo‐keto reductase genes , 2000, Genes to cells : devoted to molecular & cellular mechanisms.
[25] A. Hara,et al. Identification of amino acid residues responsible for differences in substrate specificity and inhibitor sensitivity between two human liver dihydrodiol dehydrogenase isoenzymes by site-directed mutagenesis. , 1997, The Biochemical journal.
[26] C. Lai,et al. Human aldose reductase: rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme. , 1995, Biochemistry.
[27] Short-chain dehydrogenases/reductases (SDR). , 1995 .
[28] F. Labrie,et al. Molecular Cloning of Human Type 3 3α-Hydroxysteroid Dehydrogenase That Differs from 20α-Hydroxysteroid Dehydrogenase by Seven Amino Acids , 1996 .
[29] M Krook,et al. Characteristics of short-chain alcohol dehydrogenases and related enzymes. , 1991, European journal of biochemistry.
[30] Hans H. Zingg,et al. Inhibition of oxytocin receptor function by direct binding of progesterone , 1998, Nature.
[31] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[32] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[33] J. Navaza,et al. AMoRe: an automated package for molecular replacement , 1994 .
[34] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[35] M. J. Bennett,et al. Structure of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase complexed with NADP+. , 1996, Biochemistry.
[36] H. Shiraishi,et al. Roles of the C-terminal domains of human dihydrodiol dehydrogenase isoforms in the binding of substrates and modulators: probing with chimaeric enzymes. , 1998, The Biochemical journal.
[37] N. Guex,et al. SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.
[38] J. Fontecilla-Camps,et al. The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors. , 1996, Structure.
[39] Wolfgang Kabsch,et al. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .
[40] D. Farb,et al. Dual activation of GABAA and glycine receptors by β-alanine : inverse modulation by progesterone and 5α-pregnan-3α-ol-20-one , 1993 .
[41] J. Strauss,et al. Induction of 20α-hydroxysteroid dehydrogenase in rat corpora lutea of pregnancy by prostaglandin F2α , 1974 .
[42] Zbigniew Dauter,et al. Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.
[43] D Bertrand,et al. Progesterone modulates a neuronal nicotinic acetylcholine receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[44] F. Labrie,et al. Human Types 1 and 3 3α-Hydroxysteroid Dehydrogenases: Differential Lability and Tissue Distribution1 , 2001 .
[45] K. Tew,et al. cDNA and deduced amino acid sequences of a human colon dihydrodiol dehydrogenase. , 1994, Biochimica et biophysica acta.
[46] M. Nakanishi,et al. Molecular cloning of two human liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isoenzymes that are identical with chlordecone reductase and bile-acid binder. , 1994, The Biochemical journal.
[47] H. Takikawa,et al. cDNA cloning and expression of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family. , 1993, The Journal of biological chemistry.